Jeffrey M. Drazen, M.D., joined the New England Journal of Medicine (NEJM) as Editor-in-Chief in July 2000. A specialist in pulmonology, Dr Drazen maintains an active research program. He has published more than 300 articles on topics such as lung physiology and the mechanisms involved in asthma.
Dr Drazen is one of the most widely cited authors in the medical profession. He has edited 6 books and co-authored hundreds of papers and journal publications. Along with being a prolific writer, an avid researcher and a brilliant physician, he also sits on advisory panels of several industry-leading pharma companies.
The NEJM has been reported by the New York Times to make close to $20 Million in profits every year, making it the richest medical publication in the world. However, the Journal has not officially made its profits public since 1979.